Biopsy, Bladder
Amyloid Beta Protein Ratio 1-42/1-40, Spinal Fluid
Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
Biopsy, Endocervix
Fungal and Yeast Diagnostic Panel, Antigen Detection
Chromosome Analysis, Products of Conception, or Stillbirth
Glutamate Receptor Ionotropic Kainate 4 (GRIK4)
Giardia lamblia Antibody, IgG
DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
Medical Test
References
Access to
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
is restricted.
Sign up now
Loading...